2018 - Even Birkeland

Born 1982, holds an M.S. in medical cell biology and finished in 2013 a PhD on genetic alterations in endometrial cancer, both at the UiB. He was until 2018 a postdoc in the Akslen group, with research interests in the field of cancer proteomics, especially related to breast cancer subtypes and the tumor microenvironment.